Literature DB >> 11844807

Chemoradiation for locally advanced cervical cancer: does it help?

Peter G Rose, Brian N Bundy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11844807     DOI： 10.1200/JCO.2002.20.4.891

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  7 in total

1.  Long-term results and prognostic factors of patients with cervical carcinoma treated with concurrent chemoradiotherapy.

Authors:  Ana Reig; Ismael Membrive; Palmira Foro; Xavier Sanz; Núria Rodríguez; Joan Lozano; Martí Lacruz; Jaume Quera; Enric Fernández-Velilla; Manuel Algara
Journal:  Clin Transl Oncol       Date:  2011-07       Impact factor: 3.405

2.  Adjuvant chemotherapy following concurrent chemoradiotherapy for uterine cervical cancer with lymphadenopathy.

Authors:  Akiko Abe; Hiroyuki Furumoto; Masato Nishimura; Minoru Irahara; Hitoshi Ikushima
Journal:  Oncol Lett       Date:  2011-12-06       Impact factor: 2.967

3.  A phase II randomized trial comparing radiotherapy with concurrent weekly cisplatin or weekly paclitaxel in patients with advanced cervical cancer.

Authors:  Fady B Geara; Ali Shamseddine; Ali Khalil; Mirna Abboud; Maya Charafeddine; Muhieddine Seoud
Journal:  Radiat Oncol       Date:  2010-09-23       Impact factor: 3.481

4.  Inverse planning for combination of intracavitary and interstitial brachytherapy for locally advanced cervical cancer.

Authors:  Kotaro Yoshio; Naoya Murakami; Madoka Morota; Ken Harada; Mayuka Kitaguchi; Kentaro Yamagishi; Shuhei Sekii; Kana Takahashi; Koji Inaba; Hiroshi Mayahara; Yoshinori Ito; Minako Sumi; Susumu Kanazawa; Jun Itami
Journal:  J Radiat Res       Date:  2013-05-31       Impact factor: 2.724

5.  Impact of boost irradiation on pelvic lymph node control in patients with cervical cancer.

Authors:  Masaru Wakatsuki; Tatsuya Ohno; Shingo Kato; Ken Ando; Shin-Ei Noda; Hiroki Kiyohara; Kei Shibuya; Kumiko Karasawa; Tadashi Kamada; Takashi Nakano
Journal:  J Radiat Res       Date:  2013-08-02       Impact factor: 2.724

6.  Target tailoring and proton beam therapy to reduce small bowel dose in cervical cancer radiotherapy : A comparison of benefits.

Authors:  Peter de Boer; Agustinus J A J van de Schoot; Henrike Westerveld; Mark Smit; Marrije R Buist; Arjan Bel; Coen R N Rasch; Lukas J A Stalpers
Journal:  Strahlenther Onkol       Date:  2017-11-03       Impact factor: 3.621

7.  Current management of cervical cancer in Poland-Analysis of the questionnaire trial for the years 2002-2014 in relation to ASCO 2016 recommendations.

Authors:  Tomasz Basta; Paweł Knapp; Paweł Blecharz; Lubomir Bodnar; Iwona Gawron; Dorota Babczyk; Magdalena Piróg; Tomasz Kluz; Anna Markowska; Anna Horbaczewska; Robert Jach
Journal:  PLoS One       Date:  2019-01-31       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.